No new cases of COVID-19 out of 294 tested

259

No new cases of COVID-19 were identified out of 294 tests performed on Thursday, March 18.

To date, there have been a total of 7,780 officially reported cases of COVID-19 with 134 deaths, 28 cases in active isolation, and 7,618 not in active isolation.

TODAY’S CAR SCORE

0.1

The COVID Area Risk (CAR) Score accounts for the incidence of new cases, how well current testing identifies these cases, and the rate of spread. The ideal long-term goal is to sustain a CAR Score of 2.5 or less, which has been shown to correlate with very low to zero COVID-related hospitalizations and deaths.

The following tables provide COVID-19 test results reported to the JIC on Friday, March 18, and reflects results from Thursday, March 18:

COVID-19 CASE COUNT

TOTAL

NEW CASES REPORTED TODAY

PAST 7 DAYS

COVID-19 CASES:

7,780

0

13

CONFIRMED CASES:

7,570

0

13

PROBABLE CASES:

210

0

0

 

COVID-19 TESTING

ON GUAM

TOTAL

NEW TESTS

REPORTED TODAY

7-DAY

% POSITIVE

DIAGNOSTIC TESTS

136,429

294

0.8%

MOLECULAR TESTS

126,532

248

0.9%

ANTIGEN TEST

9,897

46

0%

SEROLOGY TESTS

361

0

50%

 

CASE BREAKDOWN

STATUS

SEX

CURRENT ISOLATION LOCATION

COVID-19 Death

134

Female

3,260

Hospital

3

Active Isolation

28

Male

4,520

Home

11

Not In Isolation

7,618

AGE GROUP

Isolation Facility

6

Civilian

7,383

0-9

487

Military

8

Military Service Member

397

10-19

799

EPI-LINK TO COVID-19 CASE

Travel History

463

20-29

1,621

Household Contact

2,091

US

403

30-39

1,446

Community Contact

1,070

Dubai

2

40-49

1,431

Workplace Contact

1,327

Japan

6

50-59

1,125

Healthcare Contact

86

Mexico

3

60-69

601

RESIDENCE

Philippines

46

70-79

200

North

4,336

Other

3

80-89

58

Central

2,060

Identified in Quarantine

421

90+

12

South

967

Homeless

4

Non-resident

102

 

COVID HOSPITAL CENSUS

Guam Memorial Hospital

Guam Regional Medical City

U.S. Naval Hospital

TOTAL

COVID ADMISSION

3

0

0

3

IN ICU

0

0

0

0

ON VENTILATOR

0

0

0

0

 

The following provides preliminary COVID-19 vaccinations reported to the JIC on Friday, March 19, for vaccinations administered from December 17 to March 18:

Vaccine Maker

1st Doses Administered

2nd Doses Administered

Total Doses Administered

Individuals Fully Immunized

Pfizer-BioNTech

21,092

15,900*

36,992

15,900

Moderna

16,402**

14,298***

30,700

14,298

Johnson & Johnson Janssen

20****

20****

TOTALS:

37,494

30,198

67,712^

30,218

*Administering second doses of Pfizer-BioNTech COVID-19 vaccinations began on January 4, 2021.

**Administering first doses of Moderna COVID-19 vaccinations began on January 8, 2021.

***Administering second doses of Moderna COVID-19 vaccinations began on January 29, 2021.

****Johnson &Johnson/Janssen COVID-19 vaccinations began on March 15 and were developed as a one dose series.

 

Total Doses Administered

Total Doses Allotted

% Administered

Doses Remaining

67,712^

87,860^^

77.07%

20,148

^As of March 18, 2021. Total doses administered and allotted doses differ as vaccinators were able to draw additional doses per vial. Additionally, the U.S. Food and Drug Administration’s February 25, 2021 revision of their Fact Sheet relative to the Pfizer-BioNTech Emergency Use Authorization now states “After dilution, one vial contains 6 doses of 0.3 mL. Vial labels and cartons may state that after dilution, a vial contains 5 doses of 0.3 mL. The information in this Fact Sheet regarding the number of doses per vial after dilution supersedes the number of doses stated on vial labels and cartons.” | ^^Reflects the previous allocation total of 86,560 and last received allocation of 1,300 Johnson & Johnson Janssen vaccines on March 8, 2021.

(JIC Release No. 607)

##